Risk factors and clinical characteristics of rectal cancer recurrence after radical surgical treatment.

follow-up multidisciplinary treatment rectal cancer recurrence risk factors

Journal

Polski przeglad chirurgiczny
ISSN: 2299-2847
Titre abrégé: Pol Przegl Chir
Pays: Poland
ID NLM: 0376426

Informations de publication

Date de publication:
12 Oct 2023
Historique:
medline: 14 2 2024
pubmed: 14 2 2024
entrez: 14 2 2024
Statut: ppublish

Résumé

<b><br>Introduction:</b> Recurrence of rectal cancer affects from 4% to even 50% of patients after surgical treatment. The incidence may be influenced by numerous factors depending on the patient, the characteristics of the tumor and the type and quality of the surgical technique used.</br> <b><br>Aim:</b> The aim of this study was to assess the clinical characteristics of rectal cancer recurrence, identify potential risk factors and role of patient surveillance after primary resection of rectal cancer.</br> <b><br>Materials and methods:</b> The study comprised patients operated on due to recurrence of rectal cancer at the Department of General and Colorectal Surgery of Medical University of Lodz between 2014 and 2020, who were in the follow-up program at the hospital's outpatient clinic after the primary surgery. Risk factors for disease recurrence were sought by analyzing the characteristics of the primary tumor, treatment history and postoperative care.</br> <b><br>Results:</b> Twenty-nine patients were included in the study, the majority (51.7%) of the patients were men. The largest group was represented by patients with stage II and III disease. The most frequently performed primary surgery was low anterior resection (LAR) (62.8%). 35% of patients received neoadjuvant treatment prior to primary surgery. We demonstrated that the lack of neoadjuvant treatment before primary surgery increases the risk of cancer recurrence nine times. Higher stage of disease at the point of primary surgery is associated with nearly seven times the risk of recurrence compared to stage I disease.</br> <b><br>Conclusions:</b> Optimal preoperative staging, reasonable neoadjuvant treatment, proper surgical technique and precise follow-up regimen are essential for further improvement of rectal cancer outcomes.</br&gt.

Identifiants

pubmed: 38353092
doi: 10.5604/01.3001.0053.9182
pii: 01.3001.0053.9182
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

27-33

Auteurs

Paweł Siwiński (P)

Department of General and Colorectal Surgery, Medical University of Lodz, Poland.

Łukasz Dziki (Ł)

Department of General and Oncological Surgery, Medical University of Lodz, Poland.

Michał Mik (M)

Department of General and Colorectal Surgery, Medical University of Lodz, Poland.

Adam Dziki (A)

Department of General and Colorectal Surgery, Medical University of Lodz, Poland.

Classifications MeSH